Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Axcella Health Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −3 vs. Q2 2021
- Shares held
- 24.0M
- −240.5K (−1.0%) vs. Q2 2021
- Total value
- $71.6M
- −$25.7M (−26.4%) vs. Q2 2021
- New holders
- 2
- 4 more added
- Sold out
- 5
- 16 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $32 |
| Q3 2023 | 15 | $17.1M |
| Q2 2023 | 30 | $10.5M |
| Q1 2023 | 29 | $23.6M |
| Q4 2022 | 35 | $15.9M |
| Q3 2022 | 34 | $58.3M |
| Q2 2022 | 34 | $69.2M |
| Q1 2022 | 38 | $87.0M |
| Q4 2021 | 35 | $50.4M |
| Q3 2021 | 35 | $71.6M |
| Q2 2021 | 38 | $97.3M |
| Q1 2021 | 44 | $121.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Axcella Health Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 328 | $977 | 0.00% | −83−20.2% | Reduced |
| JPMorgan Chase & Co | 207 | $1.00K | 0.00% | −1,373−86.9% | Reduced |
| Global Retirement Partners, LLC | 180 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 400 | $1.19K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 654 | $2.00K | 0.00% | −2,676−80.4% | Reduced |
| Wells Fargo & Company | 1,105 | $3.00K | 0.00% | −9−0.8% | Reduced |
| Tower Research Capital LLC (TRC) | 893 | $3.00K | 0.00% | +893 | New |
| Morgan Stanley | 1,746 | $5.00K | 0.00% | −653−27.2% | Reduced |
| First Manhattan Co | 2,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2,316 | $7.00K | 0.00% | −859−27.1% | Reduced |
| UBS Group AG | 5,639 | $16.0K | 0.00% | −1,126−16.6% | Reduced |
| HighTower Advisors, LLC | 10,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| TownSquare Capital, LLC | 11,950 | $36.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 15,502 | $45.0K | 0.00% | −31,486−67.0% | Reduced |
| Edgewood Management LLC | 25,000 | $74.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 25,155 | $75.0K | 0.00% | +25,155 | New |
| Northern Trust Corp | 33,529 | $100.0K | 0.00% | −1,629−4.6% | Reduced |
| Cutter & CO Brokerage, Inc. | 35,300 | $105.0K | 0.03% | 00.0% | Unchanged |
| HRT Financial LP | 37,142 | $110.0K | 0.00% | −6,752−15.4% | Reduced |
| Marshall Wace, LLP | 40,017 | $119.0K | 0.00% | −32,405−44.7% | Reduced |
| Bank of New York Mellon Corp | 43,572 | $129.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 46,309 | $138.0K | 0.00% | −46,379−50.0% | Reduced |
| Ergoteles LLC | 46,457 | $138.0K | 0.01% | −17,558−27.4% | Reduced |
| Renaissance Technologies LLC | 50,266 | $150.0K | 0.00% | −107,936−68.2% | Reduced |
| State Street Corp | 70,676 | $211.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 90,474 | $270.0K | 0.00% | −26,969−23.0% | Reduced |
| Zacks Investment Management | 118,469 | $353.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 140,497 | $418.0K | 0.00% | +3,614+2.6% | Added |
| Bridgeway Capital Management, LLC | 170,409 | $508.0K | 0.01% | +32,442+23.5% | Added |
| BlackRock Inc. | 296,178 | $883.0K | 0.00% | −1,108−0.4% | Reduced |
| Artal Group S.A. | 712,500 | $2.12M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 910,909 | $2.71M | 0.00% | +1,520+0.2% | Added |
| HarbourVest Partners LLC | 2,807,981 | $8.37M | 0.79% | 00.0% | Unchanged |
| FMR LLC | 5,726,695 | $17.1M | 0.00% | +68,330+1.2% | Added |
| Flagship Pioneering Inc. | 12,548,414 | $37.4M | 0.39% | 00.0% | Unchanged |
| First Trust Advisors LP | 0 | $0 | 0.00% | −45,013−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −33,424−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,305−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −4,593−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −109−100.0% | Sold out |